跳至主要内容
临床试验/NCT00203671
NCT00203671已完成不适用

Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation

University of California, Los Angeles0 个研究点目标入组 651 人开始时间: 2006年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
651

研究概览

简要总结

The purposes of this study are:

  • To review past clinical use of mycophenolate mofetil (MMF) in kidney transplant patients;
  • To discover why doses were modified and how those modifications affected the survival and health of the transplanted kidney; and
  • To determine whether, therefore, the side effects of MMF that result in dose alterations are related to outcome.

详细描述

Objectives:

We propose collecting data on the MMF total daily dose and regimens used in our transplant population from 1995 to 2003. We will assess why doses were modified and how those modifications affected graft survival, and whether, therefore, the side effects of MMF that result in dose alterations are related to outcome.

Implementation

  1. Phase I - To describe initial MMF dosing and subsequent changes
  2. Phase II - To explore the potential effect of the above on graft outcomes
  3. Phase III - To explore reasons for dose changes and how these relate to tolerability

PHASE I

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Renal transplant recipients of either a cadaveric or living donor kidney.
  • 18 years of age or older.

排除标准

  • Multiple organ transplant recipients.
  • Prior kidney transplant recipients.

研究者

申办方类型
Other

相似试验